WP
RETA

Woodline Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Woodline Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-205,108
Closed -$20.9M – 789
2023
Q2 		$20.9M Buy
+205,108
New +$20.9M 0.25% 116
2021
Q2 		– Sell
-5,121
Closed -$511K – 663
2021
Q1 		$511K Sell
5,121
-67,976
-93% -$6.78M 0.01% 390
2020
Q4 		$9.04M Buy
+73,097
New +$9.04M 0.24% 121